A survey of attitudes of clinicians towards the diagnosis and treatment of mild cognitive impairment in Australia and New Zealand

International Psychogeriatrics

Volumn 20, Issue 1, 2008, Pages 77-85

  Mitchell, Terry ^a   Woodward, Michael ^b   Hirose, Yuichi ^c  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b HEIDELBERG REPATRIATION HOSPITAL   (Australia)

^c VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Aged; Attitude of health personnel; Cognitive disorders; Questionnaires

Indexed keywords

ARTICLE; ATTITUDE TO ILLNESS; AUSTRALIA; CLINICAL PRACTICE; COGNITIVE DEFECT; DEMENTIA; DISEASE SEVERITY; FAMILY; FOLLOW UP; HUMAN; NEW ZEALAND; PHYSICIAN; PHYSICIAN ATTITUDE; PSYCHOTHERAPY; QUESTIONNAIRE;

AGE FACTORS; ALZHEIMER DISEASE; ATTITUDE OF HEALTH PERSONNEL; AUSTRALIA; COGNITION DISORDERS; DATA COLLECTION; DIAGNOSIS, COMPUTER-ASSISTED; DISEASE PROGRESSION; FOLLOW-UP STUDIES; GERIATRICS; HUMANS; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; NEW ZEALAND; PATIENT CARE; PATIENT CARE MANAGEMENT; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL-FAMILY RELATIONS; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TERMINOLOGY AS TOPIC;

EID: 37149052782     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610207005583     Document Type: Article

References (35)

1. Anderson, M. J. (2001). A new method for non-parametric multivariate analysis of variance. Austral Ecology, 26, 32-46.
2. Bamford, C., Lamont, S., Eccles, M., Robinson, L., May, C. and Bond, J. (2004). Disclosing a diagnosis of dementia: a systematic review. International Journal of Geriatric Psychiatry, 19, 151-169.
3. Bennett, D. A., Schneider, J. A., Bienias, J. L., Evans, D. A. and Wilson, R. S. (2005). Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology, 64, 834-841.
4. Bennett, D. A. et al. (2006). Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology, 66, 1837-1844.
5. Chételat, G. et al. (2005). FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase, 11, 14-25.
6. Galvin, J. E. et al. (2005). Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Archives of Neurology, 62, 758-765.
7. Ganguli, M., Dodge, H. H., Shen, C. and DeKosky, S. T. (2004). Mild cognitive impairment, amnestic type: an epidemiologic study. Neurology, 63, 115-121.
8. Gauthier, S. et al. (2006). Mild cognitive impairment. Lancet, 367, 1262-1270.
9. Gillespie, N. D. and McMurdo, M. E. T. (1999). A survey of attitudes and knowledge of geriatricians to driving in elderly patients. Age and Ageing, 28, 53-57.
10. Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K. and Minthon, L. (2006). Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurology, 5, 228-234.
11. Hofman, A. et al. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet, 349, 151-154.
12. Howieson, D. B., Holm, L. A., Kaye, J. A., Oken, B. S. and Howieson, J. (1993). Neurologic function in the optimally healthy oldest old: neuropsychological evaluation. Neurology, 43, 1882-1886.
13. Jicha, G. A. et al. (2006). Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Archives of Neurology, 63, 674-681.
14. Korf, E. S. C., Wahlund, L. O., Visser, P. J. and Scheltens, P. (2004). Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology, 63, 94-100.
15. Larrieu, S. et al. (2002). Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology, 59, 1594-1599.
16. McArdle, B. H. and Anderson, M. J. (2001). Fitting multivariate models to community data: a comment on distance-based redundancy analysis. Ecology, 82, 290-297.
17. McGuinness, B., Todd, S., Passmore, P. and Bullock, R. (2006). Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. The Cochrane Database of Systematic Reviews, Issue 2. Art. no.: CD004034. DOI: 10.1002/14651858. CD004034.pub2.
18. Mayor, S. (2005). Regulatory authorities review use of galantamine in mild cognitive impairment. BMJ, 330, 276.
19. Morris, J. C. and Cummings, J. (2005). Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease. Journal of Alzheimer's Disease, 7, 235-239.
20. Petersen, R. C. (2004). Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 256, 183-194.
21. Petersen, R. C. and Bennett, D. (2005). Mild cognitive impairment: is it Alzheimer's disease or not? Journal of Alzheimer's Disease, 7, 241-245.
22. Petersen, R. C. and Knopman, D. S. (2006). MCI is a clinically useful concept. International Psychogeriatrics, 18, 394-402.
23. Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L. and DeKosky, S. T. (2001). Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 56, 1133-1142.
24. Petersen, R. C. et al. (2005). Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine, 352, 2379-2388.
25. Petersen, R. C. et al. (2006). Neuropathologic features of amnestic mild cognitive impairment. Archives of Neurology, 63, 665-672.
26. PROGRESS Collaborative Group. (2003). Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine, 163, 1069-1075.
27. Ritchie, K., Artero, S. and Touchon, J. (2001). Classification criteria for mild cognitive impairment: a population-based validation study. Neurology, 56, 37-42.
28. Schiff, R., Sacares, P., Snook, J., Rajkumar, C. and Bulpitt, C. J. (2006). Living wills and the Mental Capacity Act: a postal questionnaire survey of UK geriatricians. Age and Ageing, 35, 116-121.
29. Small, S. A. (2001). Age-related memory decline: current concepts and future directions. Archives of Neurology, 58, 360-364.
30. Small, S. A., Stern, Y., Tang, M. and Mayeux, R. (1999). Selective decline in memory function among healthy elderly. Neurology, 52, 1392-1396.
31. Thal, L. J. et al. (2005). A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology, 30, 1204-1215.
32. Tian, J., Bucks, R. S., Haworth, J. and Wilcock, G. (2003). Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. Journal of Neurology, Neurosurgery, and Psychiatry, 74, 433-438.
33. Visser, P. J. and Brodaty, H. (2006). MCI is not a clinically useful concept. International Psychogeriatrics, 18, 402-409.
34. Whitehouse, P. J., Gaines, A. D., Lindstrom, H. and Graham, J. E. (2005). Anthropological contributions to the understanding of age-related cognitive impairment. Lancet Neurology, 4, 320-326.
35. Zelinski, E. M. and Burnight, K. P. (1997). Sixteen-year longitudinal and time lag changes in memory and cognition in older adults. Psychology and Aging, 12, 503-513.